Introduction {#sec1-1}
============

After respiratory infections, urinary tract infections (UTIs) as one of the most common bacterial infections are considered human. Several studies suggest that Gram-negative bacilli, including *Enterobacteriaceae* bacteria family, are the most common microorganisms in the appearance of UTIs. In the meantime, *E. coli is causing more than 81% of cases of UTIs*;\[[@ref1][@ref2]\] afterward, *Staphylococcus saprophyticus, Klebsiella, Enterobacter, Proteus*, and *Enterococci* have identified as the causes of UTIs.\[[@ref3]\] Quick and accurate diagnosis of UTI is very important to shorten the course of illness, as well as to prevent disease progression toward upper UTIs and renal impairment.\[[@ref4]\] Resistances to antibiotics in different parts of the world due to genetic changes in strains, diversity in the use of antibiotics, and division in the availability to broad-spectrum of new antibiotics are different.\[[@ref5]\] In many infectious diseases including UTIs, a physician needs to start the treatment before a definitive diagnosis of infection cause and antibiogram; therefore, to administer the appropriate antibiotic, the physician must have sufficient information about the probable cause of infection and antibiotic susceptibility;\[[@ref6]\] hence, UTI agents and their antibiotic resistance are identified in each region to start treatment before culture and antibiotic sensitivity test results.\[[@ref5][@ref7]\] Studies to identify the pathogens responsible for UTIs and antibiotic resistance are significant to their specific therapy to eradicate the infectious agent.\[[@ref8][@ref9]\] According to the numerous studies in the field of bacterial drug resistance patterns of UTIs, for validating the results of this study to give more precise and valid results, the current study is carried out through systematic review and meta-analysis.

Methods {#sec1-2}
=======

A database was built for the most common resistance pattern of bacteria that causes UTIs in Iran from 1991 to 2015 using internal and external databases, including Scientific Information Database, Magiran, IranDoc, IranMedex, MedLib, PubMed, Web of Science, Scopus, and Google Scholar. Search was limited to research papers about the most common bacterial causing UTIs and their antibiotic resistance patterns that have published in Persian and English magazines. The keywords, titles, and abstracts were used by Boolean operator assistance. Keywords involved are UTIs, Gram-negative bacteria, Gram-positive bacteria, antibiotics, and antibiotic resistance. Likewise, titles and search results were evaluated and their suitability was determined for potential inclusion in the study. Furthermore, the references of selected articles were examined. Related studies in the list of references for inclusion in the study were selected.

Inclusion and exclusion criteria {#sec2-1}
--------------------------------

All cross-sectional or group studies were considered in relation to antibiotic resistance patterns of bacteria that cause UTIs. Study selection for inclusion in the assessment was done in three stages based on papers review: title, abstract, and full text. In some cases, due to ambiguity in the results of a study, the author should be contacted by for more information. Related studies involved the prevalence of bacteria causing UTIs and antibiotic resistance pattern. Studies excluded from the analysis in each of the following reasons: studies that had insufficient information, studies not included in epidemiological studies, studies not included in cross-sectional studies, and studies that have relation with other infections than UTIs. Furthermore, overview studies, summary of congresses, studies published in other languages except for Persian and Latin, systematic studies and meta-analyses, and repetitive publications were excluded from the analysis.

Data extraction {#sec2-2}
---------------

The data extracted from all studies were first author, publication year, study year, study location, sample size, average and age group, gender, type of insulation, urinary pathogen prevalence, bacterial factors, resistance to different antibiotics, antibiotic susceptibility test methods, and antibiotics susceptibility report criteria \[[Table 1](#T1){ref-type="table"}\]. Abstract and full-text search and examination were performed independently by two people, and if the results did not have any corresponding together, studies coexamined jointly to resolve the dispute.

###### 

General data and specifications reviewed articles in the meta-analysis

  First author                      Publishing year   Study year   Location of study          Number of samples   The Prevalence of Pathogens (percent)                                                            
  --------------------------------- ----------------- ------------ -------------------------- ------------------- --------------------------------------- ------ ------ ------ ------ ----- ------ ------ -------- ------
  Molazadeh\[[@ref74]\]             1391              1383         Western Azerbaijan         1900                \-                                      \-     \-     \-     \-     \-    \-     \-     \-       39.3
  Mohajeri\[[@ref75]\]              1390              1387         Kermanshah                 1114                \-                                      \-     \-     \-     \-     \-    \-     \-     \-       75
  Molazadeh\[[@ref7]\]              1393              91-92        Fasa                       2484                \-                                      5.4    \-     \-     \-     \-    \-     \-     16.6     76.3
  Mosavian\[[@ref76]\]              1383              1382         Ahvaz                      38                  \-                                      18     \-     6      \-     \-    \-     14     20       34
  Madani\[[@ref77]\]                1387              1358         Kermanshah                 1815                \-                                      \-     \-     \-     \-     \-    \-     \-              45.4
  Sorkhi\[[@ref78]\]                1384              1381         Babol                      188                 \-                                      \-     \-     \-     \-     \-    \-     \-              59.5
  Ghoutaslou\[[@ref79]\]            1384              91-92        Tabriz                     213                 \-                                      5.2    9      4.2    \-     \-    \-     \-     10.3     79
  Norouzi\[[@ref80]\]               1379              1377         Tehran                     313                 \-                                      1.6    12.7   5.9    \-     \-    \-     3.2    4.6      53.5
  Alaie\[[@ref81]\]                 1387              84-83        Tehran                     510                 \-                                      2.4    7.6    \-     \-     \-    \-     6.1    9        72
  Torabi\[[@ref82]\]                1368              1385         Zanjan                     118                 \-                                      3.9    \-     \-     \-     \-    \-     15.9   17.3     48.4
  Hajizade\[[@ref83]\]              1382              1381         Tehran                     150                 \-                                      \-     4      5      8      \-    \-     19     10       50
  Eghbalian\[[@ref84]\]             1384              83-84        Hamedan                    156                 \-                                      6.4    2.6    \-     \-     2.6   \-     5.1    2.6      82
  Jarsiah\[[@ref72]\]               1393              90-91        Tehran                     208                 \-                                      \-     5.8    3.4    \-     \-    \-            6.2      73.1
  Mirmostafa\[[@ref85]\]            1392              1379         Karaj                      100                 \-                                      \-     \-     \-     \-     6     \-            3        83
  Mobasher\[[@ref86]\]              1381              139          Gorgan                     33                  \-                                      \-     3      3      \-     3     \-     30.3   15.2     33.3
  Asgharian\[[@ref87]\]             1391              89-90        Tenekanon                  307                 \-                                      \-     \-     \-                  \-                     84.6
  Sharif\[[@ref88]\]                1378              74-76        Kashan                     152                 \-                                      0.8    \-     \-     \-     \-    \-     \-     14-Jul   52
  Rahimi\[[@ref89]\]                1393              90-91        Esfahan                    301                 \-                                             2.3    2                   0.65   11.3   7.3      65.5
  Mokhtarian\[[@ref90]\]            1385              80-84        GONABAD                    353                 \-                                      \-     3.4    \-     \-     \-    \-     21.8   7.9      66
  Assefzadeh\[[@ref91]\]            1383              1386         Ghazvin                    224                 \-                                      3.1    2.7    10.3          2.2   3.1    7.2    8.9      61.2
  Tarhani\[[@ref64]\]               1382              80-81        Khoram abad                127                 \-                                      3.1    12.6   \-     \-     0.8   \-     \-     9.4      23.2
  Hamid-Farahani\[[@ref92]\]        1391              87-88        Tehran                     456                 8.6                                     \-     \-     \-     \-     2     3.3    22.1   13       60.3
  Mohammadi\[[@ref93]\]             1385              1380         Falavarjan                 209                 \-                                      6.2    2.9    2.4    \-     \-    1.4    17.2   15.8     54.1
  Fahimi\[[@ref94]\]                1382              75-82        Tehran                     120                 \-                                             0.5    1.1    \-     \-           2.8    2.9      61.1
  Saedi\[[@ref95]\]                 1392              89-91        Mashhad                    102                 \-                                      \-     \-     4.5    14.5   \-    14.5   1.3    15.4     16.3
  Yazdi\[[@ref96]\]                 1389              88-89        Tehran                     444                 \-                                      \-     \-     \-     \-     \-    \-     \-     \-       55.4
  Yadollahi\[[@ref97]\]             1381              71-76        Chaharmahal va Bakhtiari   202                 \-                                      6.5    2.5    0.8    \-     \-    \-     2.5    7.5      80
  Soleimani\[[@ref98]\]             1392              91-92        Semnan                     100                 \-                                      \-     \-     \-     \-     \-    \-     \-     \-       70
  Moulana                           1392              87-88        Babol                      770                                                         12.1   \-     \-     \-     \-    5.9    8      17.9     48.6
  Heidari-soreshjani\[[@ref100]\]   1392              90-91        Chaharmahal va Bakhtiari   74                  4.5                                     \-     \-     \-     \-     \-    \-     20.3   \-       70.3
  Soltan Dallal\[[@ref101]\]        1390              88-89        Tabriz                     400                                                         \-     \-            \-     \-    \-     \-     \-       47
  Yazdi\[[@ref102]\]                1392              \-           Tehran                     300                 22.3                                    \-     \-     \-     \-     \-    22.3   77.7            
  Fesharakinia\[[@ref103]\]         1391              88-89        Birjand                    100                 \-                                      \-     11     \-     \-     \-    \-     \-     \-       75
  Jalalpour\[[@ref104]\]            1388              1387         Esfahan                    91                  \-                                      \-     \-     \-     \-     \-    \-            15.4     84.6
  Mohammadimehr\[[@ref105]\]        1390              86-87        Tehran                     77                  \-                                      6.5    9.1    13     10.3   1.3   \-     \-     13       45.4
  Sahebnagh\[[@ref106]\]            1393              1392         Tehran                     1123                \-                                      \-     \-     \-     \-     \-    \-     \-     \-       50
  Safkhani\[[@ref107]\]             1393              1392         Tehran                     136                 \-                                      \-     4.4    \-     \-     1.5   8.8    13.2   11.8     51.5
  Soltan Dallal\[[@ref101]\]        1393              91-92        Tehran                     400                 \-                                      \-     \-     \-     \-     \-    \-     \-     24       \-
  Asghari Moghadam\[[@ref108]\]     1393              89-90        Tehran                     116                 \-                                      \-     \-     10.3   \-     \-    \-     \-     \-       \-
  Mortazavi\[[@ref109]\]            1393              1391         Yasouj                     200                 \-                                      \-     \-            \-     \-    \-                     61.5
  Asadi Manesh\[[@ref5]\]           1393              1391         Yasouj                     145                 \-                                      3.5    6.2    2.8    \-     \-    \-     3.4    10.3     72.4
  Dehbashi\[[@ref110]\]             1393              92-93        Tehran                     522                 10.3                                    \-     \-     \-     \-     \-    \-     \-     \-       \-
  Savadkoohi\[[@ref111]\]           1392              89-90        Babol                      128                 \-                                      \-     \-     4.1    \-     \-    \-     \-     3.1      8.9
  Sharif\[[@ref112]\]               1393              91-92        Kashan                     180                 \-                                      \-     1.7    1.1    2.8    1.2   5.6    4.4    19.4     64.3
  Isvand\[[@ref3]\]                 1393              1391         Dezfool                    160                 3.1                                     1.9    \-     1.3    \-     2.5   \-     4.4    20.1     63.3
  Esmaeili\[[@ref113]\]             1392              90-91        Hamedan                    141                 \-                                      10.7   7.1    7.9    \-     \-    \-     8.5             61
  Hosseini\[[@ref114]\]             1393              91-92        Ghazvin                    12.4                \-                                      \-     \-     \-     \-     \-    \-     \-     10.6     61.1
  Shahraki\[[@ref115]\]             1393              1391         Zahedan                    122                 \-                                      \-     \-     \-            \-    \-     \-     8.2      \-
  Bagheri\[[@ref116]\]              1393              90-91        Gorgan                     111                 \-                                      26.1   6.3    13.5   1.8    \-    \-     \-     40.5     \-
  Molazade\[[@ref117]\]             1393              91-93        Fasa                       283                 \-                                      5.7    5.7           \-     \-    \-     6.4    14.5     64.3
  Molazade\[[@ref118]\]             1393              91-92        Fasa                       24-84               \-                                      5.8    3.5    1.7    \-     \-    \-     \-     23.9     64.7
  Molaabaszadeh\[[@ref119]\]        1392              1390         Tabriz Fasa                5701                \-                                      \-     \-     \-     \-     \-    \-     \-              58.4
  Farajnia\[[@ref120]\]             1388              86           Tabriz                     676                 \-                                      1.2    1.2    2.7    \-     \-    1.2    8      11.7     74.6
  Ahangarkani\[[@ref121]\]          1393              92-93        Babol                      128                 \-                                      \-     \-     \-     \-     \-    \-     \-     \-       78
  Nasiri\[[@ref122]\]               1379              78-79        Birjand                    111                 \-                                      \-     \-     \-     \-     \-    \-     \-     \-       65
  Savadkoohi\[[@ref111]\]           1386              82-83        Babol                      160                 \-                                      11.9   3.1    6.3    \-     \-    \-     6.5    \-       70
  Panahi\[[@ref123]\]               1387              80-84        Tehran                     28                  \-                                                    17.9   \-     \-    \-     17.9   43       21.4
  Esmaeili\[[@ref124]\]             1384              80-81        Mashhad                    166                 \-                                      1.8    6      0.6    \-     2.4   3.6    4.3    7.2      74.1
  Jalalpoor\[[@ref125]\]            1390              88-89        Esfahan                    211                 \-                                      \-     \-     \-     \-     \-    \-     \-     14       64
  Jalalpoor\[[@ref125]\]            1390              88-89        Esfahan                    167                 \-                                      \-     \-     \-     \-     \-    \-     \-     15       52
  Zamanzad\[[@ref126]\]             1384              1383         Shahre Kord                100                 \-                                      2      \-     6      \-     \-    \-     12     38       42
  Zamanzad\[[@ref126]\]             1384              1383         Shahre Kord                100                 \-                                      6      4      2      \-     1     \-     7      16       58
  Norouzi\[[@ref127]\]              1385              1            Jahrom                     351                 \-                                      3.7    56     1.4    \-     1.2   \-     0.84   10.7     80.3
  Abdolahi\[[@ref128]\]             1383              86-87        Tehran                     5400                15.7                                    1.3    2.3    \-     \-     0.8   2      14.1   8.8      44.5

Statistical analysis {#sec2-3}
--------------------

With regard to the prevalence of antibiotic resistances and sample numbers that were obtained in each article, for calculating the variance of each study and combined with the amounts of various studies, the prevalence of binomial distribution and weighted average were used, respectively. However, weight was given to each study proportional to its variance inverse. Due to the large difference in prevalence in different studies (heterogeneity in studies) and know the significance of the homogeneity index (*I*^2^), the random-effects model was used in the meta-analysis.

Results {#sec1-3}
=======

As a result of the initial search, 184 articles were obtained. In the next stage, 34 articles were rejected based on titles and abstracts assessment and the full-text 150 articles remained were studied. After this, 137 papers were selected to be involved the next stage. Then, 47 articles were eliminated (8 reviews, 19 duplicates, 7 low-quality articles, and 13 articles due to insufficient information). Finally, after a precise review of selected articles, 90 studies conducted in 1991--2015 have been entered in the meta-analysis \[[Figure 1](#F1){ref-type="fig"}\]. General specifications and data sheet are depicted in [Table 1](#T1){ref-type="table"}.

![Studies entry to systematic review and meta-analysis](IJPVM-10-169-g001){#F1}

In reviewing studies in this meta-analysis, by a total number of urine samples collected in national and private laboratories, based on standard methods, 35,118 people with UTI (65.37% female and 34.63% male), also 78.40% of urinary infections were common outpatient and hospitalized patients were 21.60%.

Among the most common pathogens causing UTIs were *E. coli, Klebsiella, Staphylococcus*, and *Streptococcus* with a frequency of 62%, 13%, 12%, and 11% took place the next ranks, respectively \[[Figure 2](#F2){ref-type="fig"}\]. Other bacteria *Enterococcus, Citrobacter, Acinetobacter, Pseudomonas, Proteus*, and *Enterobacter* had a marginal role in UTI with the frequency of 2% \[[Table 2](#T2){ref-type="table"}\].

![Resistances rate of Escolar isolates to Ampicillin based on a random-effects model. The midpoint of each piece represents an estimate of the prevalence, each piece represents a confidence interval of 15% in each study and diamond mark is indicative of all the studies in the whole country](IJPVM-10-169-g002){#F2}

###### 

Frequency distribution of bacteria causing UTIs examined in the meta-analysis

  *P*      Heterogeneity index *I*^2^ (%)   Confidence interval (CI%95)   Prevalence   The number of studies   Bacteria type
  -------- -------------------------------- ----------------------------- ------------ ----------------------- ------------------
  \<.001   97.9                             58-65                         62%          58                      *E. coli*
  \<.001   95.6                             11-15                         13%          44                      *Klebsiella*
  \<.001   98                               0.09-15                       12%          32                      *Staphylococcus*
  \<.001   96                               0.06-16                       11%          6                       *Streptococcus*
  \<.001   91.5                             0.04-0.07                     05%          12                      *Enterococcus*
  \<.001   26.4                             0.01-0.02                     01%          14                      *Citrobacter*
  \<.001   79.6                             0.03-10                       06%          5                       *Acinetobacter*
  \<.001   72.8                             0.02-0.04                     03%          28                      *Pseudomonas*
  \<.001   82.6                             0.03-0.04                     04%          28                      *Proteus*
  \<.001   93                               0.04-0.07                     05%          28                      *Enterobacter*
  \<.001   91.6                             1.2-2.4                       1.76         15                      Other Species

Resistance of *E. coli* to different antibiotics in the included studies at meta-analysis is summarized in [Table 3](#T3){ref-type="table"}. The analysis results of the most common resistance isolates causing UTIs to antibiotics are given in [Table 4](#T4){ref-type="table"}. As it can be seen, there is most resistance among *E. coli* isolates to ampicillin (86%) \[[Figure 2](#F2){ref-type="fig"}\], amoxicillin (76%), tetracycline (71%), trimethoprim-sulfamethoxazole (64%), cephalexin (61%), and cefalothin (60%) antibiotics. Likewise, the lowest rate of resistance had been observed in imipenem (14%) \[[Figure 3](#F3){ref-type="fig"}\], nitrofurantoin (18%), amikacin (21%), chloramphenicol (28%), and ciprofloxacin (28%) antibiotics, and the resistance of *E. coli* isolates as compared to other used antibiotics was as follows: gentamicin (32%), ceftriaxone (35%), cefazolin (48%), cefixime (45%), nalidixic acid (43%), cefotaxime (42%), and ceftazidime (40%).

###### 

*E. coli* resistance rate (%) to different antibiotics in the articles reviewed in the meta-analysis

  First Author                       *Chloramphenicol*   *Nitrofurantoin*   *Imipenem*   *Cefalotin*   *Cephalexin*   *Cefixime*   *Cefotaxime*   *Ceftriaxone*   *Ceftazidime*   *Nalidixic acid*   *Ciprofloxacin*   *Amikacin*   *Gentamicin*   *Tetracycline*   *Amoxicillin*   *Ampicillin*   *Cotrimoxazole*
  ---------------------------------- ------------------- ------------------ ------------ ------------- -------------- ------------ -------------- --------------- --------------- ------------------ ----------------- ------------ -------------- ---------------- --------------- -------------- -----------------
  Molazadeh\[[@ref74]\]              \-                  5.5                \-           48.9          \-             \-           \-             \-              \-              24.8               19                \-           11.5           \-               \-              84             60.3
  Mohajeri\[[@ref75]\]               \-                  6.7                \-           52            45.9           28.6         24.8           29              24.2            43.2               30.1              4.7          14.8           74.2             86              83.4           58.7
  Molazadeh\[[@ref7]\]               \-                  11.9               \-           49            \-             43.4         \-             40              \-              56                 30.9              \-           31             \-               \-              \-             59.4
  Mosavian\[[@ref76]\]               47.1                29.8               \-           \-            94.1           \-           \-             \-              \-              11.8               \-                \-           23.5           \-               \-              100            35.3
  Madani\[[@ref77]\]                 \-                  8.5                11.8         66.7          41.4           46.8         30.4           29.8            38.8            38.5               25.5              32.3         43.3           \-               \-              91.4           61.1
  Sorkhi\[[@ref78]\]                 \-                  30                 \-           \-            86             \-           \-             6               \-              20                 \-                7.5          18.5           \-               \-              91             81
  GHoutaslou\[[@ref79]\]             \-                  26.7               \-           \-            \-             \-           \-             \-              \-              22.5               4.3               18.3         40             \-               \-              95.5           64.7
  Nourozi\[[@ref80]\]                \-                  \-                 \-           \-            \-             \-           \-             \-              \-              \-                 \-                \-           \-             \-               \-              \-             78.1
  Alaie\[[@ref81]\]                  \-                  20.6               \-           \-            62.8           \-           \-             17.2            \-              16.4               9                 6            15.4           \-               \-              78.9           66
  Torabi\[[@ref82]\]                 \-                  \-                 \-           \-            \-             \-           \-             \-              \-              \-                 \-                \-           \-             \-               \-              \-             57.4
  Hajizadeh\[[@ref83]\]              \-                  88                 \-           656           \-             \-           \-             \-              \-              5                  \-                \-           \-             \-               50              85             72
  Eghbalian\[[@ref84]\]              \-                  12.5               \-           \-            \-             \-           \-             34.4            \-              25                 15.6              15.8         25             75               \-              78.1           34.4
  Jarsiah\[[@ref72]\]                \-                  0.7                0            \-            \-             33.1         \-             \-              34.7            55.8               28.2              9.1          14.9           \-               \-              \-             65.5
  Mirmostafa\[[@ref85]\]             16.9                8.4                25.3         48.2          61.5           \-           38.5           37.3            27.7            56.6               32.5              18           28.2           63.6             83              \-             59
  Asgharian\[[@ref87]\]              \-                  63                 \-           76            \-             97           97             64              99              84                 52                81           54             91               96.5            95             83
  Sharif\[[@ref88]\]                 \-                  \-                 \-           51.5          \-             \-           \-             \-              \-              \-                 \-                \-           \-             \-               \-              87.7           56.3
  Rahimi\[[@ref89]\]                 \-                  4                  \-           \-            \-             \-           31             32              \-              73                 1                 \-           28             \-               \-              72             70
  Mokhtarian\[[@ref90]\]             \-                  39.3               \-           \-            73             \-           \-             \-              \-              44.6               9.4               36.9         50.2           \-               100             99.1           62.2
  Assefzadeh\[[@ref91]\]             \-                  27.6               29.6         \-            \-             \-           \-             46.7            \-              \-                 46.7              28           42             \-               \-              84.2           61.5
  Tarhani\[[@ref64]\]                \-                  11.8               \-           \-            \-             4.7          \-             3.1             \-              7.1                3.1               2.4          9.4            \-               63              65             54.3
  Hamid-Farahani\[[@ref92]\]         \-                  5                  \-           \-            \-             25.6         \-             \-              \-              \-                 21.3              \-           27.7           \-               \-              80.7           37
  Mohammadi\[[@ref93]\]              23.4                \-                 \-           \-            \-             \-           \-             \-              \-              87.9               8.3               31.1         6.9            44.8             91              91             63.4
  Fahimi\[[@ref94]\]                 \-                  5.9                \-           \-            37.1           \-           \-             2.9             \-              5.9                \-                5.9          11.8           \-               \-              92.9           75.3
  Saedi\[[@ref95]\]                  \-                  7.6                7.2          \-            \-             \-           \-             38.4            38.4            \-                 15.3              7.6          23             \-               \-              53.8           \-
  Yazdi\[[@ref102]\]                 \-                  \-                 8.3          \-            \-             \-           39.2           \-              47.1            50                 33.3              \-           \-             \-               \-              \-             \-
  Yadollahi\[[@ref97]\]              \-                  40                 \-           \-            95             \-           \-             \-              \-              68                 \-                80           6.9            \-               9.5             95             \-
  Soleimani\[[@ref98]\]              \-                  4                  \-           \-            \-             \-           \-             \-              \-              \-                 22                0            18             \-               \-              72             42
  Moulana\[[@ref99]\]                \-                  17.3               \-           \-            \-             \-           \-             \-              \-              \-                 \-                \-           21.7           \-               \-              98.4           69.3
  Heidari-soureshjani\[[@ref100]\]   \-                  5.2                \-           \-            \-             37.5         \-             43.9            \-              78.8               46.5              7.7          10             \-               \-              85.7           42.4
  Soltan Dallal\[[@ref101]\]         14                  \-                 \-           \-            \-             \-           43             \-              42              35                 56                \-           29             \-               82              \-             65
  Fesharakinia\[[@ref103]\]          \-                  26.2               \-           \-            51.7           23.1         \-             23.9            25.8            33.8               \-                \-           20.9           \-               \-              \-             69.9
  Jalalpour\[[@ref104]\]             \-                  16.7               \-           \-            \-             \-           \-             \-              19.5            54.9               30.3              \-           27.8           \-               \-              \-             59.2
  Sahebnagh\[[@ref106]\]             \-                  2.2                \-           \-            \-             \-           \-             42.5            27.3            \-                 48.7              0.5          24.1           \-               \-              80.3           61.4
  Safkhani\[[@ref107]\]              \-                  1.4                \-           \-            \-             \-           \-             34.8            27              \-                 17.9              2.9          18.2           \-               \-              76.8           60
  Mohammadimehr\[[@ref105]\]         \-                  \-                 \-           \-            \-             \-           39             \-              17.9            51.2               22.8              \-           \-             \-               \-              \-             \-
  Savadkoohi\[[@ref111]\]            \-                  7.6                15           \-            49             35           28             35.4            \-              51                 28                9.5          19             \-               \-              87.5           62.3
  Sharif\[[@ref112]\]                \-                  49.1               \-           \-            78.9           54.4         \-             41.2            \-              25.4               \-                \-           \-             \-               88.6            90.4           \-
  Isvand\[[@ref3]\]                  \-                  11.1               \-           \-            \-             \-           \-             \-              \-              34.7               11.3              \-           17.7           \-               \-              96.6           11.2
  Esmaeili\[[@ref113]\]              \-                  2.3                \-           \-            \-             \-           \-             46.5            \-              1.2                24.4              \-           17.4           \-               90.7            \-             28
  Hosseini\[[@ref114]\]              \-                  23                 \-           \-            \-             \-           18.6           \-              25              46.6               15.9              20           22             \-               79.9            72.6           48
  Molazade\[[@ref117]\]              \-                  21.5               \-           62.3          \-             57.2         \-             43.5            \-              52.4               17.2              \-           31.4           \-               \-              \-             66.5
  Molazade\[[@ref118]\]              \-                  16.4               \-           64.1          69.6           61.6         66.7           56.6            \-              66.8               36                10.2         34.4           62.1             \-              100            68.7
  Molaabaszadeh\[[@ref119]\]         \-                  11                 8            \-            \-             \-           26.7           33              \-              44                 27                32           43.1           81               \-              84             63.9
  Farajnia\[[@ref120]\]              \-                  12.9               \-           \-            24             \-           \-             \-              \-              6.3                6                 2.2          3              \-               \-              93.1           \-
  Ahangarkani\[[@ref121]\]           \-                  \-                 \-           \-            \-             34           \-             \-              \-              \-                 34                \-           \-             \-               \-              \-             67
  Nasiri\[[@ref122]\]                \-                  \-                 \-           \-            14             \-           \-             \-              \-              \-                 \-                \-           \-             \-               86              \-             65
  Savadkoohi\[[@ref111]\]            \-                  21.4               \-           \-            54.5           \-           \-             17.9            \-              25                 \-                6            17             \-               \-              94.6           67
  Esmaeli\[[@ref124]\]               \-                  3.3                \-           0             20.8           2.5          0              15              \-              17.4               2.5               0.9          5.2            \-               \-              \-             75.8
  Zamanzad\[[@ref126]\]              \-                  62                 \-           62            \-             \-           \-             \-              \-              57                 \-                \-           81             \-               \-              100            76.2
  Zamanzad\[[@ref126]\]              \-                  17.2               \-           43            \-             \-           \-             \-              \-              17.2               \-                \-           36.2           \-               \-              77.6           65.5
  Norouzi\[[@ref127]\]               \-                  \-                 \-           \-            \-             \-           \-             \-              \-              28.7               16.2              16.3         28.1           \-               \-              \-             51
  Abdolahi\[[@ref128]\]              \-                  6                  1            \-            \-             \-           41             \-              \-              \-                 \-                32           28             \-               \-              89             \-
  Sharifi\[[@ref129]\]               7.5                 \-                 0.8          100           \-             \-           \-             \-              41.6            48.3               28.3              5            20.8           55               76.6            \-             62.5
  Borji\[[@ref130]\]                 \-                  17.1               \-           \-            \-             \-           \-             2.5             \-              21.2               9.4               \-           24.8           \-               \-              91.1           80.5
  Barati\[[@ref131]\]                \-                  3                  \-           \-            23.6           \-           \-             13.5            \-              28.6               \-                \-           8.9            \-               53.4            65.9           47
  Farshad\[[@ref132]\]               35.4                3.1                \-           \-            \-             19.7         \-             \-              10.4            25                 8.3               3.1          15.6           70.8             \-              80.2           76
  Tajvidi\[[@ref133]\]               \-                  \-                 29           \-            \-             39           \-             30              \-              \-                 30                \-           22             \-               \-              \-             51
  Ranjbaran\[[@ref134]\]             56                  18                 \-           \-            \-             \-           73             76              72              \-                 29                27           74             60               74              \-             88
  Beheshti\[[@ref135]\]              \-                  1                  \-           47.6          \-             \-           \-             \-              \-              33                 26.2              \-           16.4           \-               \-              84.5           64.1
  Beheshti\[[@ref135]\]              \-                  2.9                \-           51            \-             \-           \-             \-              \-              45.1               32.4              \-           18.6           \-               \-              90.2           71.6
  Babaie\[[@ref136]\]                \-                  20                 \-           \-            \-             93.3         \-             100             83.3            \-                 83.3              13.3         63.3           86.7             96.7            \-             93.3
  Tashkori\[[@ref137]\]              \-                  12.3               \-           58.9          \-             \-           28.1           30.1            27.4            39.7               21.9              \-           15.6           \-               \-              \-             62.3
  Momeni mofrad\[[@ref65]\]          \-                  3                  \-           \-            \-             \-           \-             \-              20              \-                 55                1            39             \-               \-              85             \-
  Naghavi\[[@ref138]\]               \-                  \-                 \-           \-            \-             \-           \-             \-              \-              52                 \-                \-           \-             \-               \-              \-             \-
  Nateghian\[[@ref139]\]             \-                  \-                 \-           \-            \-             \-           \-             38.4            \-              \-                 \-                \-           24             \-               \-              \-             \-
  Zibaei\[[@ref140]\]                \-                  \-                 \-           \-            \-             \-           \-             \-              \-              82.8               43                \-           \-             \-               \-              \-             \-
  Fallah\[[@ref141]\]                49                  33.5               27.1         60            \-             \-           \-             \-              38.1            57.4               36.2              32.1         46.4           \-               78              \-             67.7
  Khodadoost\[[@ref142]\]            \-                  \-                 \-           \-            \-             \-           25             24.3            15.7            \-                 31.4              \-           16.4           \-               \-              81.4           62.1
  Ghadiri\[[@ref143]\]               \-                  \-                 \-           \-            \-             35.6         \-             39.1            \-              44.8               \-                14.9         20.7           \-               \-              \-             72.4
  soleimaifard\[[@ref144]\]          \-                  3.3                \-           \-            \-             53.3         \-             56.7            \-              73.3               40                0            16.7           \-               \-              93.3           \-
  Akya\[[@ref145]\]                  \-                  \-                 \-           \-            \-             \-           46             45.2            26.1            \-                 37                \-           24.7           \-               \-              83             57.5
  Dezfolimanesh\[[@ref146]\]         \-                  \-                 12.5         \-            \-             \-           49.7           49.7            35.9            \-                 34.1              11.2         36.8           \-               \-              79.1           55.6
  Sedighi\[[@ref147]\]               \-                  6                  \-           \-            \-             44           \-             \-              \-              60                 \-                2            18             \-               \-              \-             70
  Neamati\[[@ref148]\]               \-                  17.3               0.7          \-            \-             \-           \-             56.7            49.3            71.3               61.3              \-           40             \-               16              81.3           64.7
  Sedighi\[[@ref149]\]               \-                  0                  \-           \-            \-             35           \-             30              \-              47                 \-                4            \-             \-               \-              \-             70
  Emam\[[@ref150]\]                  13.3                34.3               \-           \-            \-             \-           \-             \-              \-              21.6               6.7               28.6         72.1           \-               \-              \-             71.4
  Sedighi\[[@ref149]\]               \-                  0                  \-           \-            \-             35           \-             30              \-              47                 \-                4            \-             \-               \-              \-             7700
  Erfani\[[@ref151]\]                \-                  \-                 \-           \-            \-             \-           \-             \-              33.2            \-                 43.6              \-           22.8           \-               \-              \-             \-
  Nakhaiemoghadam\[[@ref152]\]       \-                  1.8                \-           \-            \-             \-           \-             \-              \-              34.9               21.1              \-           12.8           \-               \-              \-             55.1

###### 

Sensitivity and resistance rate to different antibiotics in selected studies to the meta-analysis

  Antibiotic        *Staphylococcus*   *Klebsiella*   *E. coli*             
  ----------------- ------------------ -------------- ----------- ---- ---- ----
  Cotrimoxazole     58                 42             54          46   64   36
  Ampicillin        87                 13             80          20   85   15
  Amoxicillin       \-                 \-             76          24   76   24
  Tetracycline      \-                 \-             53          47   71   29
  Gentamicin        49                 51             38          62   32   68
  Amikacin          41                 59             27          73   21   79
  Ciprofloxacin     20                 80             19          81   28   72
  Nalidixic acid    51                 49             33          67   43   57
  Ceftazidime       \-                 \-             40          60   40   60
  Ceftriaxone       66                 34             40          60   35   65
  Cefotaxime        \-                 \-             38          62   42   58
  Cefixime          \-                 \-             53          47   45   55
  Cephalexin        72                 28             67          33   61   39
  Cefalotin         43                 57             55          45   60   40
  Imipenem          \-                 \-             13          87   14   86
  Nitrofurantoin    42                 58             42          58   18   82
  Chloramphenicol   \-                 \-             47          53   28   72

![Resistances rate of *E.coli* isolates to Imipenem based on a random-effects model. The midpoint of each piece represents an estimate of the prevalence, each piece represents a confidence interval of 15% in each study and diamond mark is indicative of all the studies in the whole country](IJPVM-10-169-g003){#F3}

In examining *Klebsiella* isolates, the lowest level of resistance to imipenem (13%), ciprofloxacin (19%), and amikacin (27%) were found. The resistance rate of *Klebsiella* isolates to other antibiotics was as follows: cefalothin (55%), trimethoprim-sulfamethoxazole (54%), tetracycline (53%), cefixime (53%), chloramphenicol (47%), nitrofurantoin (42%), ceftazidime (40%), ceftriaxone (40%), gentamicin (38%), cefotaxime (38%), and nalidixic acid (33%). In *Staphylococcus* isolates, the highest rate of resistance to ampicillin (87%), cephalexin (72%), and ceftriaxone (66%) antibiotics and the lowest rate of resistance to ciprofloxacin (20%) antibiotic was observed; furthermore, a resistance rate had also been seen in antibiotics of sulfamethoxazole (58%), nalidixic acid (51%), gentamicin (49%), cephalothin (43%), nitrofurantoin (42%), and amikacin (41%).

Discussion and Conclusions {#sec1-4}
==========================

In the current study, the prevalence rate of UTI in women was several times more than men (women,65.37% and men, 34.63%). In studies conducted in other parts of the world such as New York,\[[@ref10]\] America,\[[@ref11][@ref12]\] Washington,\[[@ref13]\] Portugal,\[[@ref14]\] Mexico,\[[@ref15]\] Nigeria,\[[@ref16][@ref17]\] Taiwan,\[[@ref18]\] India,\[[@ref19]\] and Pakistan,\[[@ref20]\] the incidence of UTIs in women also was higher. The results of these studies are consistent with the results of our study, due to anatomical differences between men and women, including a short urethra and its external opening adjacent to the vagina and anus in women.\[[@ref21][@ref22]\]

The current study showed that *Enterobacteriaceae* family bacteria are the most common causes of UTIs; due to the presence of these bacteria in the digestive tract, a possible UTI may occur.\[[@ref9]\] In the present study, *E. coli* was the most common pathogen that causes UTI; this result has to correspond to more studies in other parts of the world. *E. coli* prevalence reported 50%--80% in Asia (58% in Saudi Arabia,\[[@ref23]\] 70% in India,\[[@ref19]\] 75.3% in Turkey,\[[@ref24]\] 65.9% in South Korea,\[[@ref25]\] 74.8% in Bangladesh,\[[@ref26]\]), 60.29% in Africa\[[@ref27]\], 90%---60% in Europe (64.5% in Portugal\[[@ref14]\] and 85.9% in Russia\[[@ref28]\]) 90%--75% in the USA,\[[@ref29]\] and 76.6% in Brazil.\[[@ref30]\] *E. coli* in the current and mentioned studies is the most common pathogen causing UTIs.

In other articles, other pathogens that cause UTIs more than *E. coli* have also been mentioned. In our study, *Klebsiella* was the second most common cause of UTIs; this result is consistent with the studies conducted in Australia,\[[@ref31]\] South Africa,\[[@ref32]\] Taiwan,\[[@ref18]\] Bangladesh,\[[@ref26]\] Pakistan,\[[@ref20]\] and India.\[[@ref33]\] However, in the studies conducted in South Korea and Europe, this had been reported that *Enterobacter* is the second UTI factor after *E. coli*.\[[@ref25][@ref34]\] In a study in Portugal on *Enterobacter* and *Klebsiella* bacteria, it has found that both bacteria have the same effect on UTIs after *E. coli*.\[[@ref14]\] In regard to carried study in France, in urinary infections after *E. coli*, Gram-positive cocci were the most common cause of infection.\[[@ref35]\] According to the current study and noted articles in this context, it is reported that the bacteria causing UTIs are approximately the same in the world. In general, *E. coli* are the most common bacteria. Then, *Klebsiella, Staphylococcus, Enterobacter*, and other species with slight differences in different geographical locations in the next category are placed. The resistance rate of *E. coli* and *Staphylococcus* ampicillin was 86% and 87%, respectively. In a study in South Korea, the resistance rates of *E. coli* and *Klebsiella* isolates to ampicillin were 6.63% and 99%, respectively.\[[@ref25]\] In the same study in Taiwan, the rates of resistance in *E. coli* and *Klebsiella* were 100% and 70%, respectively.\[[@ref18]\] *E. coli* resistance to ampicillin in studies conducted in Bangladesh was 80%,\[[@ref36]\] Ethiopia 80%,\[[@ref27]\] Mexico 79%,\[[@ref37]\] UAE 72%,\[[@ref38]\] Brazil 55%,\[[@ref39]\] Turkey, 74%,\[[@ref40]\] Greece 50%,\[[@ref41]\] and America 48%.\[[@ref42]\] Studies in North America, Canada, and Lebanon have reported similar results.\[[@ref43][@ref44][@ref45]\] In the present and cited studies, the abundance of resistance to ampicillin was higher than other antibiotics. However, in the cited cases, as it can be seen, countries such as America, Brazil, and Greece had a lower rate of resistance than this study. The results of these studies suggest that antibiotics such as ampicillin are practically useless and even recommended not to be used for antibiogram.

In this study, the resistance rate of *E. coli* after ampicillin compared with amoxicillin (76%) and tetracycline (71%) higher. In a study in Ethiopia, the sensitivity of *E. coli* to amoxicillin was 15.4%, tetracycline was 17.8%, and ampicillin was 20%; for *Klebsiella*, it has been reported 30% to amoxicillin, 34.6% to tetracycline, and 8.1% to ampicillin.\[[@ref26]\] In the same study as the current one, almost total resistance to amoxicillin, ampicillin, and tetracycline in the aforementioned isolates exists. The resistance to amoxicillin in urinary tract pathogens is similar to other studies that have conducted in other parts of the world, for example, the *E. coli* resistance to these antibiotics has been reported to be 85% in Ethiopia,\[[@ref26]\] 67.5% in Senegal,\[[@ref46]\] and 72% in India.\[[@ref47]\] In Turkey, the rate of this resistance in separate studies had increased from 32.7% to 50% in 2009 and 2013.\[[@ref24][@ref48]\] In a Spanish study, *E. coli* antibiotic resistance at 2005, 2009, and 2011 was examined; the results showed that resistance to amoxicillin had increased from 4.5% in 2005 to 55.6% in 2011.\[[@ref49]\] In a study in European countries, the resistance rate to amoxicillin was reported to be 48% in Poland and 60% in Belgium.\[[@ref50]\] In all of these studies, the higher resistance to amoxicillin had reported, although the results of the current study similar to developing countries. Resistance to tetracycline in *E. coli* and *Klebsiella* isolates in Ethiopian\[[@ref27]\] and Senegal\[[@ref46]\] studies was similar to the present study. In this study, amoxicillin and tetracycline were taking place in another group of ineffective drugs. The reason for such resistance may be the somewhat irregular use of medication among patients, whether by prescription or willfulness, so they are not recommended as a treatment for UTI.

Cotrimoxazole is another antibiotic that is prescribed for UTI treatment. According to the results, all of the studied bacteria were resistant to the cotrimoxazole. *E. coli* resistance to cotrimoxazole in most developing countries illustrates similar results. For example, the rate of this resistance was 68.1% in Senegal,\[[@ref46]\] 58% in Turkey,\[[@ref24]\] and 53% in Lebanon.\[[@ref45]\] Unlike the results of this study, some studies, especially that conducted on isolates of *E. coli* in developed countries, have reported low resistance to cotrimoxazole. For example, the rate of resistance in the studies conducted in Italy,\[[@ref51]\] Canada,\[[@ref44]\] Croatia,\[[@ref52]\] America,\[[@ref43]\] and Australia\[[@ref31]\] was reported to be 27.1%, 22%, 20.59%, 21.3%, and 14.5%, respectively.

In the current study, based on resistance rate to antibiotics tetracycline and cotrimoxazole in uropathogenic *E. coli* (UPEC), it can be said that the antibiotic resistance rate of in Iran is higher than some developed countries. This difference may be due to the strains of microorganisms, self-medication by patients, incomplete treatment course, prescribe inappropriate antibiotics by physicians, the dosage of medication, manufacturer-based drug quality, relying on empirical treatment regardless of culture and antibiotic susceptibility test results. Therefore, strict measures of clinical practitioners should be put at the head of affairs, for infection control and prevention from resistance spread.

Furthermore, in the present study, quinolone family antibiotics such as nalidixic acid ( first generation) and ciprofloxacin (second generation) were studied. In this study, resistance rates to nalidixic acid in *E. coli, Klebsiella*, and *Staphylococcus* were reported as 43%, 33%, and 51%, respectively, which shows the relatively high resistance. Regarding the past nalidixic acid in the first step used in treating UTIs, therefore, higher resistance is expected to these antibiotics than the other quinolone family antibiotics\[[@ref51]\] that correspond with the findings of our study in this case. In Ethiopia, *E. coli* sensitivity rate to nalidixic acid, 86% reported\[[@ref27]\] that toward the present study is higher but in Bangladesh has the lowest sensitivity (27%);\[[@ref36]\] likewise, in Pakistan, resistance to nalidixic acid in urinary isolates of *E. coli*, 84.16% reported.\[[@ref53]\] The results of these two studies are very different from the current study results that may be produced by overuse of cited drugs in developing countries without exact surveillance.

The high sensitivity to ciprofloxacin in all isolates (*E. coli* 72%, *Klebsiella* 81%, and *Staphylococcus* 80%) had been found. *E. coli* resistance to ciprofloxacin in the most done studies by other researchers reported, for example, resistance rates in Nigeria, Ethiopia, Senegal, India, South Korea, Turkey, Mexico, America, North America, Canada, Italy, and Germany about 5.5%--31.9%.\[[@ref24][@ref25][@ref27][@ref43][@ref44][@ref46][@ref51][@ref54][@ref55][@ref56][@ref57][@ref58]\] The resistance rate in urinary isolates of *E. coli* to ciprofloxacin in studies done in Pakistan and Bangladesh\[[@ref36][@ref53]\] was medium while in Lebanon with a frequency of 54% was too high. In this study, like many other studies, it has been determined that urinary tract pathogens have high sensitivity to quinolones and particularly ciprofloxacin that can be used as the first drug in the treatment of patients with UTI.\[[@ref59]\] In Talon *et al.*\'s study, fluoroquinolones had been recommended for the uncomplicated UTI treatment, especially when resistance to cotrimoxazole in a society does not exceed from 20% to 10%.\[[@ref60]\] In general, this study illustrates that ciprofloxacin still can be used as the first-line therapy of UTIs in Iran.

Aminoglycosides are another group of antibiotics that are used in UTIs. In this study also, isolates resistant to amikacin and gentamicin were evaluated in this category. Resistance to amikacin in *E. coli* 21%, *Klebsiella* 27% and *Staphylococcus* 41% reported. Resistance to gentamicin in *E. coli*, Klebsiella, and Staphylococcus was reported to be 32%, 38%, and 49%, respectively. In most studies similar to our study, high sensitivity to amikacin was reported in UPEC. For example, *E. coli* sensitivity to amikacin in India was found to be 90.6%,\[[@ref61]\] Saudi 93.7%,\[[@ref61]\] South Korea 99.4%,\[[@ref25]\] and Taiwan 100%.\[[@ref18]\] Similarly, *E. coli* resistance to amikacin in Brazil was found to be 2%,\[[@ref39]\] America 0%,\[[@ref42]\] and China 11.7%.\[[@ref62]\] In a study conducted in North America and Europe, *E. coli* sensitivity to amikacin was found to be about 98.5%--97.8%.\[[@ref63]\] *Klebsiella* sensitivity to amikacin in South Korea was reported to be 95%\[[@ref25]\] and Taiwan 100%,\[[@ref18]\] which is consistent with our results.

In this study, founded relatively high sensitivity to gentamicin in *E. coli*, but sensitivity to gentamicin in Staphylococcus and Klebsiella obtained the average. *E. coli* sensitivity to gentamicin in South Korea was reported as 74.2%,\[[@ref25]\] Taiwan 77%,\[[@ref18]\] and Ethiopia 66%.\[[@ref27]\] Likewise, in the study conducted in Europe, the resistance of *E. coli* to aminoglycosides was reported to be about 4.21%--5.2%.\[[@ref64]\] These results are consistent with the results of our study. *Klebsiella* sensitivity to gentamicin in both South Korea\[[@ref25]\] and Taiwan 95%\[[@ref18]\] that toward to our study was higher, but in Ethiopia, 57.1% was reported,\[[@ref27]\] which corresponds to the results of this study. In a study in China, most *E. coli* isolates resistance to gentamicin (95.1%) was also reported.\[[@ref62]\] The reasons for the difference in the frequency of resistance to aminoglycosides in above studies than ours can be the various distributions of resistance genes in different geographical areas, consumption of antibiotics, and prescribing pattern. Gentamicin is one of the drugs that can be used as initial treatment of UTIs until the culture results prepared. One of the interesting features about old antibiotics such as gentamicin and amikacin is good penetration into the bacteria cell.\[[@ref65]\] however, due to the increased use and availability of gentamicin, its resistance is greater than other aminoglycosides in many regions, and on the other hand, less resistance to amikacin, the frequency of resistance to these effective and inexpensive drugs varies from region to region. For these reasons, antimicrobial susceptibility testing required before treatment. The results of this study showed that amikacin could be used as the first-line therapy for the treatment of UTIs in Iran. However, in the case of gentamicin, since the resistance rate of these organisms to gentamicin in the present study obtained as 32%--49%, it is a kind of alarm for the spread of organisms resistant to these antibiotics and is recommended to be taken with caution.

In the present study, cephalexin and cefalotin (the first generation of cephalosporins) investigated. All isolates causing UTI were resistant to cephalexin. *E. coli* also had a high resistance to cefalotin, but *Klebsiella* and *Staphylococcus* had an intermediate resistant to these antibiotics. Furthermore, ceftazidime, ceftriaxone, cefotaxime, and cefixime (third-generation cephalosporins) investigated. The resistance rate of studied isolates to these group antibiotics was 65%--55%. Ethiopian,\[[@ref27]\] Senegal,\[[@ref46]\] and Lebanon\[[@ref45]\] studies were consistent with the current study in this case. In these studies, intermediate resistance has reported in isolates of *Escherichia* to cephalosporins, but in the study of Taiwan, high sensitivity was observed in *E. coli* (cefazolin 81%, ceftriaxone 74%, and ceftazidime 89%) and also in isolates of *Klebsiella* (cefazolin 80%, ceftriaxone 85%, and ceftazidime 83%);\[[@ref18]\] in South Korea, high sensitivity to cephalosporins was observed in *E. coli* (cefotaxime 89.4%, ceftazidime 89.2% and cephalotin 58.4%) and in *Klebsiella* (cefotaxime 78.8%, ceftazidime 77.8%, and cephalotin 70.5%)\[[@ref25]\] has reported. A conducted study in Europe suggested *E. coli* resistance to the third generation of cephalosporins was around 19.2%--1.8%\[[@ref64]\] and also low resistance has reported to these antibiotics in America.\[[@ref57]\] In more advanced countries that have better performance in health and planning level, resistance to these antibiotics is less than Iran. Furthermore, in Greece, resistance to cefotaxime and ceftazidime 3.7% and 4% has been reported, respectively.\[[@ref66]\] The different results of these studies than current study could be more accurate monitoring programs in that country and the unavailability of these drugs. This pharmaceutical group is the most common drugs in the treatment of infections, due to the high function and a wide range effect, but the results of this study and other studies indicative increasing resistance to these drugs in our country. In many countries such as Iran, this family of antibiotics is suitable as antimicrobial agents used in the treatment of UTIs, and this could be one of the main reasons for resistance to these antibiotics. Therefore, to avoid increasing resistance to this antibiotic group being used with caution and intransitive proceedings should be done.

In the present study, isolates were most sensitive to imipenem (86% in *E. coli* and 87% in *Klebsiella*). *E. coli* sensitivity to imipenem in Taiwan was 100%,\[[@ref18]\] South Korea 100%,\[[@ref25]\] India 98.89%,\[[@ref55]\] Saudi Arabia 91.71%,\[[@ref61]\] Turkey 93%,\[[@ref24]\] and Europe and North America 99.7% and 99.8%,\[[@ref63]\] respectively. Likewise, *Klebsiella* sensitivity to imipenem in Taiwan\[[@ref18]\] and South Korea both was 100%\[[@ref25]\] that these results were consistent with the results of this study. As mentioned above, the most effective antimicrobial agent was imipenem in this study that was consistent with the results of previous studies. This resistance reduction could be due to the limitation of drug usage in nosocomial infections, lack of necessary conditions (intravenous injection) in UTIs treatment in outpatients, lack of access to this drug, as well as being more expensive in compared with other drugs.\[[@ref67]\]

In *E. coli*, highest sensitivity obtained to nitrofurantoin 82% after imipenem, but moderate sensitivity to these antibiotics was observed in *Staphylococcus* and *Klebsiella* isolates (58% each). In the United Kingdom\[[@ref68]\] and extensive studies conducted in both America and Canada, very low resistance prevalence has been reported in urinary isolates of *E. coli* to nitrofurantoin (1.1% and 4%).\[[@ref43][@ref44]\] In studies conducted in China and Saudi Arabia, *E. coli* resistance rate to nitrofurantoin was 8% and 6.5%--2.4% reported, respectively.\[[@ref69][@ref70]\] The sensitivity of *E. coli* to nitrofurantoin in Ethiopia was 89.6%\[[@ref27]\] and India 77.4% reported.\[[@ref19]\] These studies are consistent with the present study. In this study, *E. coli* has a high sensitivity to chloramphenicol (72%), which is consistent with other studies.\[[@ref19][@ref24][@ref27]\] According to the results of this study, the use of imipenem and nitrofurantoin antibiotics suggests because of their positive role has been evaluated by various articles. The UTIs are the most common infections seen in all parts of the world. However, the infection is not threatening, but if specific therapy is done, its side effects can be very severe.\[[@ref21][@ref71][@ref72]\] The initial treatment of the infection is often experimental, and antibiotics selection depends on various factors such as intensity of symptoms, drug toxicity, and the effectiveness of treatment; however, the common types of urinary pathogens in the community and their susceptibility antimicrobial patterns are effective in antibiotic selection.\[[@ref73]\] It is noteworthy that this antibiotic resistance of these bacterial agents is different in diverse parts of the world. Hence, in the treatment of urinary infections, antibiotic selection should be based on knowledge of the region, and international reports are not an appropriate choice for antimicrobial drug selection.\[[@ref68][@ref74]\] Due to the additive prevalence of resistance to antibiotics, early and timely diagnosis of the resistant bacterial isolates is considered necessary, to select appropriate treatment options and prevent the proliferation of resistance.

Limitations {#sec2-4}
-----------

The limitations of this study were the lack of resistance rate estimation in urinary uropathogenic for all antibiotics used in Iran, due to the lack of information in this field of compiled researches. Nonentity of calculation for antibiotic resistance rate in isolates that cause UTIs in males and females separately is one of the limitations of this study because only a limited number of resistance studies were calculated separately for these genders. In most studies, age category is one of the affecting factors on mentioned resistance rate; however, due to nonentity in mentioning of the age group in a large number of studies and also due to the lack of entity similar age groups in the number of other studies, we could not calculate the resistance rate in terms of age; another limitation of this study was the lack of determined resistance rate by type of patient admission because such information did not exist in large number of compiled studies.

Conclusions {#sec1-5}
===========

According to the present study, *E. coli* was the most common cause of UTI, and after that, *Klebsiella*, *Staphylococcus aureus*, and *Enterobacter* rank the next category. The results of this study showed that resistance is likely to be against the most common used antibiotics. The most effective antibiotics for *E. coli* are imipenem, nitrofurantoin, amikacin, chloramphenicol, and ciprofloxacin. By considering the results of this study, less use of gentamicin, the second generation of cephalosporins and nalidixic acid recommended, on the other hand, consuming of the penicillin, tetracycline, trimethoprim-sulfamethoxazole and the first generation of cephalosporins prescribed in the initial treatment of infections caused by *E. coli*. For *Klebsiella* isolates that separate from urine samples, effective antibiotics are imipenem, ciprofloxacin, amikacin, and nalidixic acid. Similarly, the use of ampicillin and cephalexin is not recommended in this case. In the treatment of UTIs that caused by *Staphylococcus*, ciprofloxacin is prescribed and consumed. It is obvious that due to the more use of antibiotics, uncontrolled use, and antibiotics misuse, antibiotic resistance emerging control is essential and this is one of the most important factors affecting these phenomena and attempts should be made for proper use of antibiotics.
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